Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Cancer immunotherapy can significantly prevent tumor growth and metastasis by activating the autoimmune system without destroying normal cells. Although cancer immunotherapy has made some achievements in clinical cancer treatment, it is still restricted by systemic immunotoxicity, immune cell dysfun...
Saved in:
Main Authors: | Tingting Hu (Author), Yuezhou Huang (Author), Jing Liu (Author), Chao Shen (Author), Fengbo Wu (Author), Zhiyao He (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
by: Ruixiang Li, et al.
Published: (2018) -
Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
by: Tingting Zhang, et al.
Published: (2022) -
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
by: Yongrong Yao, et al.
Published: (2022) -
Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy
by: Yuan Gao, et al.
Published: (2023) -
Nanomedicines for Overcoming Cancer Drug Resistance
by: Tingting Hu, et al.
Published: (2022)